Bionano Genomics (BNGO) Inventory Average (2018 - 2026)

Bionano Genomics' Inventory Average history runs 9 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• In Q1 2026, Inventory Average fell 48.0% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (down 48.0% YoY), while the FY2025 annual figure was $8.3 million, down 51.29% from the prior year.
• Inventory Average came in at $5.4 million for Q1 2026 at Bionano Genomics, down from $6.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $32.8 million in Q2 2023 to a low of $5.4 million in Q1 2026.
• A 5-year average of $18.3 million and a median of $18.4 million in 2022 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average soared 365.04% in 2022 and sank 53.6% in 2025, its largest moves.
• Bionano Genomics' Inventory Average stood at $27.4 million in 2022, then dropped by 10.01% to $24.7 million in 2023, then slumped by 48.41% to $12.7 million in 2024, then slumped by 50.88% to $6.2 million in 2025, then declined by 13.94% to $5.4 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $5.4 million, $6.2 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison